SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-18-009486
Filing Date
2018-07-20
Accepted
2018-07-20 17:17:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D sc13d0718a4kidron_oramed.htm SC 13D/A 67795
2 LETTER AGREEMENT BETWEEN NADAV KIDRON AND XIAOPENG LI, DATED NOVEMBER 21, 2016. sc13d0718a4ex10-2kidron_oram.htm EX-10.2 5326
  Complete submission text file 0001213900-18-009486.txt   74551
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13D/A | Act: 34 | File No.: 005-79895 | Film No.: 18963092
SIC: 2834 Pharmaceutical Preparations

Mailing Address 142 W. 57TH ST. NEW YORK NY 10019
Business Address
KIDRON NADAV (Filed by) CIK: 0001351779 (see all company filings)

Type: SC 13D/A